Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MYND Life Sciences C.MYND

Alternate Symbol(s):  MYNDF

MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.


Stock Price Chart (CSE:MYND)

Fundamentals Snapshot (CSE:MYND)

Opinion & Analysis (CSE:MYND)

No current opinion is available.

Bullboard Posts (CSE:MYND)

RE:MYND Life Sciences Inc. Achieves a Major Milestone

Under the radar...maybe
wealth100 - April 7, 2023

MYND Life Sciences Inc. Achieves a Major Milestone

This seems like a major development, but not much reaction in the stock ... ------------------------ Identification of a potent...
AVandelay - March 15, 2023

MYND Life Sciences celebrates Dr. Wilf Jefferies milestone

MYND Life Sciences celebrates Dr. Wilf Jefferies induction as a National Academy of Inventors Fellow
BMcCutcheon - June 17, 2022

MYND announces innovation in psilocybin dosing

https://themarketherald.ca/mynd-life-sciences-announces-new-testing-methodologies-for-measuring-cellular-responses-to-microdosing-with...
TrevorAbes - June 1, 2022

MYND Life Sciences announces private placement

https://themarketherald.ca/mynd-life-sciences-announces-3-5-million-share-offering-2022-04-22/
jballem - April 27, 2022

Participation in a Monash University (Australia) Proposal

 Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression VANCOUVER, BC, Oct. 13...
Betteryear2 - October 13, 2021